# Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

> **NCT00885989** · PHASE1 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SLV338
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00885989
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2010-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885989, "Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00885989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*